User profiles for Barnaby C. Reeves

Barnaby Reeves

University of Bristol
Verified email at bristol.ac.uk
Cited by 63473

The versatility and absolute efficiency of detecting mirror symmetry in random dot displays

HB Barlow, BC Reeves - Vision research, 1979 - Elsevier
The detection of mirror symmetry has been investigated by measuring discriminability (d')
between two populations of dot displays that contain mirror pairs and random dots in different …

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

JAC Sterne, MA Hernán, BC Reeves, J Savović… - bmj, 2016 - bmj.com
Non-randomised studies of the effects of interventions are critical to many areas of healthcare
evaluation, but their results may be biased. It is therefore important to understand and …

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial

…, SM Downes, AJ Lotery, S Wordsworth, BC Reeves… - Ophthalmology, 2012 - Elsevier
PURPOSE: To compare the efficacy and safety of ranibizumab and bevacizumab intravitreal
injections to treat neovascular age-related macular degeneration (nAMD). DESIGN: …

RoB 2: a revised tool for assessing risk of bias in randomised trials

…, T Lasserson, T Li, A McAleenan, BC Reeves… - bmj, 2019 - bmj.com
Assessment of risk of bias is regarded as an essential component of a systematic review on
the effects of an intervention. The most commonly used tool for randomised trials is the …

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

BJ Shea, BC Reeves, G Wells, M Thuku, C Hamel… - bmj, 2017 - bmj.com
The number of published systematic reviews of studies of healthcare interventions has
increased rapidly and these are used extensively for clinical and policy decisions. Systematic …

Including non‐randomized studies

BC Reeves, JJ Deeks, JPT Higgins… - Cochrane handbook for …, 2008 - Wiley Online Library
This chapter has been prepared by the Non-Randomised Studies Methods Group (NRSMG)
of The Cochrane Collaboration (see Box 13.8. a). It is intended to support review authors …

[HTML][HTML] Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

…, SM Downes, AJ Lotery, LA Culliford, BC Reeves - The Lancet, 2013 - thelancet.com
Background Bevacizumab has been suggested to have similar effectiveness to ranibizumab
for treatment of neovascular age-related macular degeneration. The Inhibition of VEGF in …

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery

GJ Murphy, BC Reeves, CA Rogers, SIA Rizvi… - Circulation, 2007 - Am Heart Assoc
Background— Red blood cell transfusion can both benefit and harm. To inform decisions
about transfusion, we aimed to quantify associations of transfusion with clinical outcomes and …

[HTML][HTML] ROBIS: a new tool to assess risk of bias in systematic reviews was developed

…, JPT Higgins, DM Caldwell, BC Reeves… - Journal of clinical …, 2016 - Elsevier
Objective To develop ROBIS, a new tool for assessing the risk of bias in systematic reviews (rather
than in primary studies). Study Design and Setting We used four-stage approach to …

Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery

BC Reeves, R Ascione, MH Chamberlain… - Journal of the American …, 2003 - jacc.org
Objectives : This study sought to quantify the effect of body mass index (BMI) on early
clinical outcomes following coronary artery bypass grafting (CABG). Background : Obesity is …